Aptus Pharma Ltd.BSE: APPL

Aptus Pharma Ltd. Press Release Apr 28 2026

· Issued by Aptus Pharma Ltd. via BSE India

Filed with BSE ·

Statement of Deviation(s) or Variation(s) in utilization of proceeds of initial Public Offer pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

View Attachment

6ix hasn’t read this filing yet.

Aptus Pharma Ltd. on 6ix

Earlier from Aptus Pharma

Later from Aptus Pharma

All Aptus Pharma news releases